688189 Hunan Nucien Pharmaceutical Co., Ltd.
- 6.56
- +0.05+0.77%
Hunan Nucien Pharmaceutical Co., Ltd. News
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Announcement of the results of shareholders who hold more than 5% of shares and have not reduced their shareholdings after the expiration of the shareholding reduction plan.
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Legal opinion of the 2023 annual shareholder meeting of Peking Dacheng (Guangzhou) Law Firm.
Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Announcement on voluntary disclosure of results from Phase II clinical trials of inhaled Remdesivir solution
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Announcement on the use of some overraised funds to permanently replenish working capital
Western Securities Co., Ltd.'s verification opinion on the company's use of part of the overfunded capital to permanently supplement working capital
Independent opinions of independent directors on matters relating to the 10th meeting of the second board of directors of the company
Announcement on holding the results briefing for the first quarter of 2023 and 2024
Notice on convening the 2023 Annual General Meeting of Shareholders
2023 Independent Director Debriefing Report (Ding Fangfei)
2023 Independent Director Debriefing Report (Han Yu Ming)
2023 Independent Director Debriefing Report (Kang Cailian)
2023 Independent Director's Debriefing Report (Nie Ruqiong)
2023 Independent Director Debriefing Report (Shen Yunqiao)
2023 Independent Director Debriefing Report (Zhang Da)
Announcement of Resolutions of the Eighth Meeting of the Second Board of Supervisors
2023 Annual General Meeting of Shareholders Meeting Materials
Analysis
Price Target
No Data
